Basic Information
RNALocate ID: | RLID:11001016 |
RNA Symbol: | hsa-miR-29b-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-29b |
RNA ID: | miRBase:MIMAT0000100 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001443 | Cytoplasm | HeLa cells | 28185889 |
RLID:01001444 | Cytoplasm | Hepatic carcinoma cells (Huh-7) | 29253196 |
RLID:01001445 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001446 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001447 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001448 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001449 | Nucleus | Hela cells|NIH-3T3 cells | 17204650 |
RLID:01001450 | Nucleus | HeLa cells | 28185889 |
RLID:01001451 | Nucleus | Hepatic carcinoma cells (Huh-7) | 29253196 |
RLID:01001452 | Nucleus | HeLa cells | 30006350 |
RLID:01001453 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:11001009 | Exosome | Urine | 26576778 |
RLID:11001010 | Exosome | HCC tissues | 30542726 |
RLID:11001011 | Exosome | Saliva | 19627513 |
RLID:11001012 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001013 | Exosome | Brain tissue | 23382797 |
RLID:11001014 | Exosome | Plasma | 23663360 |
RLID:11001015 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID-D:11000034 | Exosome | Breast milk|Epithelial cells|Seminal fluid|Tongue tissue | |
RLID-D:11000299 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-29b-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-35224 |
MNDR | hsa-miR-29b-3p | Oral squamous cell carcinoma | MNDR-E-MI-35225 |
MNDR | hsa-miR-29b-3p | Large cell neuroendocrine cancer | MNDR-E-MI-35226 |
MNDR | hsa-miR-29b-3p | Medulloblastoma | MNDR-E-MI-35227 |
MNDR | hsa-miR-29b-3p | B cell lymphoma of malt type | MNDR-E-MI-35228 |
MNDR | hsa-miR-29b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-35229 |
MNDR | hsa-miR-29b-3p | Ovarian clear cell carcinoma | MNDR-E-MI-35230 |
MNDR | hsa-miR-29b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-35231 |
MNDR | hsa-miR-29b-3p | Spinocerebellar ataxia type 17 | MNDR-E-MI-35232 |
MNDR | hsa-miR-29b-3p | Lymphoma | MNDR-E-MI-35233 |
MNDR | hsa-miR-29b-3p | Non-hodgkin lymphoma | MNDR-E-MI-35234 |
MNDR | hsa-miR-29b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-35235 |
MNDR | hsa-miR-29b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-35236 |
MNDR | hsa-miR-29b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-35237 |
MNDR | hsa-miR-29b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-35238 |
MNDR | hsa-miR-29b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-35239 |
MNDR | hsa-miR-29b-3p | Breast cancer luminal | MNDR-E-MI-35240 |
MNDR | hsa-miR-29b-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-35241 |
MNDR | hsa-miR-29b-3p | Prostate cancer | MNDR-E-MI-35242 |
MNDR | hsa-miR-29b-3p | Chronic lymphocytic leukemia | MNDR-E-MI-35243 |
MNDR | hsa-miR-29b-3p | Gastric cancer | MNDR-E-MI-35244 |
MNDR | hsa-miR-29b-3p | Alzheimer disease | MNDR-E-MI-35245 |
MNDR | hsa-miR-29b-3p | Intracranial aneurysm | MNDR-E-MI-35246 |
MNDR | hsa-miR-29b-3p | Sarcoma | MNDR-E-MI-35247 |
MNDR | hsa-miR-29b-3p | Dysautonomia familial | MNDR-E-MI-35248 |
MNDR | hsa-miR-29b-3p | Myotonic dystrophy | MNDR-E-MI-35249 |
MNDR | hsa-miR-29b-3p | Duchenne muscular dystrophy | MNDR-E-MI-35250 |
MNDR | hsa-miR-29b-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-35251 |
MNDR | hsa-miR-29b-3p | Primary biliary cirrhosis | MNDR-E-MI-35252 |
MNDR | hsa-miR-29b-3p | Leukemia | MNDR-E-MI-35253 |
MNDR | hsa-miR-29b-3p | Huntington disease | MNDR-E-MI-35254 |
MNDR | hsa-miR-29b-3p | Chorea | MNDR-E-MI-35255 |
MNDR | hsa-miR-29b-3p | Cardiovascular disease | MNDR-E-MI-35256 |
MNDR | hsa-miR-29b-3p | Uterine fibroid | MNDR-E-MI-35257 |
MNDR | hsa-miR-29b-3p | Lung cancer | MNDR-E-MI-35258 |
MNDR | hsa-miR-29b-3p | Down syndrome | MNDR-E-MI-35259 |
MNDR | hsa-miR-29b-3p | Parkinson disease | MNDR-E-MI-35260 |
MNDR | hsa-miR-29b-3p | Basal-like breast cancer | MNDR-E-MI-35261 |
MNDR | hsa-miR-29b-3p | Thyroid cancer | MNDR-E-MI-35262 |
MNDR | hsa-miR-29b-3p | Pancreatic cancer | MNDR-E-MI-35263 |
MNDR | hsa-miR-29b-3p | Melanoma | MNDR-E-MI-35264 |
MNDR | hsa-miR-29b-3p | Rectum adenocarcinoma | MNDR-E-MI-35265 |
MNDR | hsa-miR-29b-3p | Nephroblastoma | MNDR-E-MI-35266 |
MNDR | hsa-miR-29b-3p | Colon cancer | MNDR-E-MI-35267 |
MNDR | hsa-miR-29b-3p | Ischemic attack transient | MNDR-E-MI-35268 |
MNDR | hsa-miR-29b-3p | Colon adenocarcinoma | MNDR-E-MI-35269 |
MNDR | hsa-miR-29b-3p | West nile virus infection | MNDR-E-MI-35270 |
MNDR | hsa-miR-29b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-35271 |
MNDR | hsa-miR-29b-3p | Prostate adenocarcinoma | MNDR-E-MI-35272 |
MNDR | hsa-miR-29b-3p | Kidney cancer | MNDR-E-MI-35273 |
MNDR | hsa-miR-29b-3p | Thyroid adenomas | MNDR-E-MI-35274 |
MNDR | hsa-miR-29b-3p | Carcinoma ductal breast | MNDR-E-MI-35275 |
MNDR | hsa-miR-29b-3p | Glioblastoma | MNDR-E-MI-35276 |
MNDR | hsa-miR-29b-3p | Astrocytoma | MNDR-E-MI-35277 |
MNDR | hsa-miR-29b-3p | Glioma | MNDR-E-MI-35278 |
MNDR | hsa-miR-29b-3p | Nemaline myopathy | MNDR-E-MI-35279 |
MNDR | hsa-miR-29b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-35280 |
MNDR | hsa-miR-29b-3p | Osteosarcoma | MNDR-E-MI-35281 |
MNDR | hsa-miR-29b-3p | Liposarcoma | MNDR-E-MI-35282 |
MNDR | hsa-miR-29b-3p | Meningioma | MNDR-E-MI-35283 |
MNDR | hsa-miR-29b-3p | Uterine cancer | MNDR-E-MI-35284 |
MNDR | hsa-miR-29b-3p | Stomach adenocarcinoma | MNDR-E-MI-35285 |
MNDR | hsa-miR-29b-3p | Lung squamous cell carcinoma | MNDR-E-MI-35286 |
MNDR | hsa-miR-29b-3p | Carcinoma lung non-small-cell | MNDR-E-MI-35287 |
MNDR | hsa-miR-29b-3p | Lung adenocarcinoma | MNDR-E-MI-35288 |
MNDR | hsa-miR-29b-3p | Adrenocortical cancer | MNDR-E-MI-35289 |
MNDR | hsa-miR-29b-3p | Thyroid carcinoma | MNDR-E-MI-35290 |
MNDR | hsa-miR-29b-3p | Papillary thyroid carcinoma | MNDR-E-MI-35291 |
MNDR | hsa-miR-29b-3p | Ovarian carcinoma | MNDR-E-MI-35292 |
MNDR | hsa-miR-29b-3p | Bladder urothelial carcinoma | MNDR-E-MI-35293 |
MNDR | hsa-miR-29b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-35294 |
MNDR | hsa-miR-29b-3p | Brain stem cancer | MNDR-E-MI-35295 |
MNDR | hsa-miR-29b-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-35296 |
MNDR | hsa-miR-29b-3p | Carcinoma renal cell | MNDR-E-MI-35297 |
MNDR | hsa-miR-29b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-35298 |
MNDR | hsa-miR-29b-3p | Renal clear cell carcinoma | MNDR-E-MI-35299 |
MNDR | hsa-miR-29b-3p | Cholangiocarcinoma | MNDR-E-MI-35300 |
MNDR | hsa-miR-29b-3p | Esophageal cancer | MNDR-E-MI-35301 |
MNDR | hsa-miR-29b-3p | Oncocytoma | MNDR-E-MI-35302 |
MNDR | hsa-miR-29b-3p | Lung small cell carcinoma | MNDR-E-MI-35303 |
MNDR | hsa-miR-29b-3p | Schizophrenia | MNDR-E-MI-35304 |
MNDR | hsa-miR-29b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-35305 |
MNDR | hsa-miR-29b-3p | Testicular germ cell cancer | MNDR-E-MI-35306 |
MNDR | hsa-miR-29b-3p | Breast invasive carcinoma | MNDR-E-MI-35307 |
MNDR | hsa-miR-29b-3p | Hepatocellular carcinoma | MNDR-E-MI-35308 |
MNDR | hsa-miR-29b-3p | Aggressive b-cell lymphoma | MNDR-E-MI-35309 |
MNDR | hsa-miR-29b-3p | Rheumatoid arthritis | MNDR-E-MI-35310 |
MNDR | hsa-miR-29b-3p | T-cell leukemia | MNDR-E-MI-35311 |
MNDR | hsa-miR-29b-3p | Retinoblastoma | MNDR-E-MI-35312 |
MNDR | hsa-miR-29b-3p | Neuroblastoma | MNDR-E-MI-35313 |
MNDR | hsa-miR-29b-3p | Barrett's adenocarcinoma | MNDR-E-MI-35314 |
MNDR | hsa-miR-29b-3p | Chronic myelogenous leukemia | MNDR-E-MI-35315 |
MNDR | hsa-miR-29b-3p | Hodgkin lymphoma | MNDR-E-MI-35316 |
MNDR | hsa-miR-29b-3p | Burkitt lymphoma | MNDR-E-MI-35317 |
MNDR | hsa-miR-29b-3p | Tonsil cancer | MNDR-E-MI-35318 |
MNDR | hsa-miR-29b-3p | Neuromyelitis optica | MNDR-E-MI-35319 |
MNDR | hsa-miR-29b-3p | Acute myeloid leukemia | MNDR-E-MI-35320 |
MNDR | hsa-miR-29b-3p | Frontotemporal dementia | MNDR-E-MI-35321 |
MNDR | hsa-miR-29b-3p | Colorectal cancer | MNDR-E-MI-35322 |
MNDR | hsa-miR-29b-3p | Nasopharynx carcinoma | MNDR-E-MI-35323 |
MNDR | hsa-miR-29b-3p | Type 2 diabetes | MNDR-E-MI-35324 |
MNDR | hsa-miR-29b-3p | Multiple myeloma | MNDR-E-MI-35325 |
MNDR | hsa-miR-29b-3p | Ependymoma | MNDR-E-MI-35326 |
MNDR | hsa-miR-29b-3p | Cardiomegaly | MNDR-E-MI-35327 |
MNDR | hsa-miR-29b-3p | Nasopharyngeal cancer | MNDR-E-MI-35328 |
MNDR | hsa-miR-29b-3p | Prostatic neoplasms | MNDR-E-MI-35329 |
MNDR | hsa-miR-29b-3p | Acute myelogeneous leukemia | MNDR-E-MI-35330 |
MNDR | hsa-miR-29b-3p | Aids dementia complex | MNDR-E-MI-35331 |
MNDR | hsa-miR-29b-3p | Epstein-barr virus infections | MNDR-E-MI-35332 |
MNDR | hsa-miR-29b-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-35333 |
MNDR | hsa-miR-29b-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-35334 |
MNDR | hsa-miR-29b-3p | Stroke lacunar | MNDR-E-MI-35335 |
MNDR | hsa-miR-29b-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-35336 |
MNDR | hsa-miR-29b-3p | Barrett's carcinogenesis | MNDR-E-MI-35337 |
MNDR | hsa-miR-29b-3p | Breast cancer her3+ negative | MNDR-E-MI-35338 |
MNDR | hsa-miR-29b-3p | Limb-girdle muscular dystrophies types 2A | MNDR-E-MI-35339 |
MNDR | hsa-miR-29b-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-35340 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACVR2A | Homo sapiens | RR00039275 |
TOP